Beginning Cash: The amount of cash reported by the company on its previous statement.
Supernus Pharmaceuticals, Inc. (SUPN) Beginning Cash data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$718.95M |
|
$-38.55M |
|
$74.56M |
|
$644.39M |
|
$781.24M |
|
$-62.28M |
|
$13.25M |
|
$-49.03M |
|
$-49.03M |
|
$-38.55M |
|
$-38.55M |
|
$-38.55M |
|
$-38.55M |
|
$-62.28M |
|
$-62.28M |
|
56.45M |
|
56.45M |
|
$-0.68 |
|
$-0.68 |
|
| Balance Sheet Financials | |
$644.18M |
|
$10.53M |
|
$808.47M |
|
$1.45B |
|
$338.17M |
|
-- |
|
$52.76M |
|
$390.93M |
|
$1.06B |
|
$367.38M |
|
$1.06B |
|
57.46M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
|
Beginning Cash |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|